Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 1:38 PM ET

Diversified Consumer Services

Company Overview of Technion Israel Institute Of Technology

Company Overview

Technion Israel Institute Of Technology is an educational institution.

Technion City




972 4 8292111

Key Executives for Technion Israel Institute Of Technology

Director at Eve Topf Neurodegenerative Diseases Research and Teaching Center
Compensation as of Fiscal Year 2015.

Technion Israel Institute Of Technology Key Developments

Sun Pharmaceutical Industries Ltd. and the Technion - Israel institute of technology Form Research Collaboration to Develop New Class of Oncology Drugs

Sun Pharmaceutical Industries Ltd. and the Technion - Israel institute of technology, announced that their respective subsidiaries have entered into an exclusive worldwide research and license agreement. This agreement aims at the development of a joint project, based on new findings by Professor Aaron Ciechanover, Dr. Gila Maor and Professor Ofer Binah, that can potentially lead to the development of novel anti-cancer drugs. The pre-clinical research was funded thus far by Dr. Alfred Mann.

Cannabics Pharmaceuticals Inc. Executes Research Agreement with Israel Institute of Technology for Screening of Potential Anticancer Cannabinoid Compounds

Cannabics Pharmaceuticals Inc. announced that it has executed a Research Agreement with the Israel Institute of Technology (Technion) in Israel, for the screening of potential Anticancer Cannabinoid compounds. Under the terms of the agreement, Cannabics Pharmaceuticals will collaborate with a researcher from the Biology Department of the Technion to develop a diagnostic system that screens the anti-cancer properties of cannabis-based active ingredients. This system would be harnessed to explore different types of cancer cells treated with a multitude of cannabinoid combinations.

Technion Israel Institute Of Technology Presents at Milken Institute Global Conference 2014, Apr-29-2014 09:30 AM

Technion Israel Institute Of Technology Presents at Milken Institute Global Conference 2014, Apr-29-2014 09:30 AM. Venue: Lon Angeles, California, United States. Speakers: Haim Bitterman, Professor of Medicine.

Similar Private Companies By Industry

Company Name Region
Alon Group Ltd. Middle East/Africa
Shagrir Towing Services Ltd. Middle East/Africa
Spetz Middle East/Africa
Easy Park Ltd. Middle East/Africa
Kidum IT Ltd. Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Technion Israel Institute Of Technology, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at